Cargando…

Efficacy of vision therapy for unilateral refractive amblyopia in children aged 7–10 years

BACKGROUND: There is a critical period for visual development, conventionally considered to be the first 6 years of life. Children aged 7 years and older are significantly less responsive to amblyopia treatment. This study investigated the efficacy of binocular vision therapy in amblyopic children a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Yi-Ching, Liao, Wen-Ling, Tsai, Yi-Yu, Lin, Hui-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805323/
https://www.ncbi.nlm.nih.gov/pubmed/35100972
http://dx.doi.org/10.1186/s12886-022-02246-9
_version_ 1784643224076288000
author Hsieh, Yi-Ching
Liao, Wen-Ling
Tsai, Yi-Yu
Lin, Hui-Ju
author_facet Hsieh, Yi-Ching
Liao, Wen-Ling
Tsai, Yi-Yu
Lin, Hui-Ju
author_sort Hsieh, Yi-Ching
collection PubMed
description BACKGROUND: There is a critical period for visual development, conventionally considered to be the first 6 years of life. Children aged 7 years and older are significantly less responsive to amblyopia treatment. This study investigated the efficacy of binocular vision therapy in amblyopic children aged 7–10 years. METHODS: This retrospective study enrolled 36 children with unilateral amblyopia who were divided into a case group (receiving vision therapy, optical correction, and part-time patching of the weaker eye) and a control group (receiving optical correction and part-time patching of the weaker eye). Visual acuity (VA) was measured at baseline, at the 3-month, 6-month, and 9-month visits, and 3 months after cessation of treatment. RESULTS: There were 19 subjects in the case group and 17 subjects in the control group. Mean VA in the case group improved from 0.39 ± 0.24 logMAR at baseline to 0.10 ± 0.23 logMAR at the endpoint of treatment (p < 0.001, paired t-test). Mean VA in the control group improved from 0.64 ± 0.30 logMAR at baseline to 0.52 ± 0.27 logMAR at the endpoint of treatment (p = 0.015, paired t-test). The improvement was significantly greater in the case group than in the control group (p = 0.006, two-samples independent t-test). All subjects underwent follow-up examinations within 6 to 12 months. There was no regression of VA in the case group 3 months after cessation of vision therapy. The patients in the case group who received visual therapy were with better VA improvement then patients with only optic correction and patching. CONCLUSIONS: Vision therapy combined with conventional treatment (optical correction and part-time patching) is more effective than conventional treatment alone in children aged 7–10 years with unilateral refractive amblyopia. The treatment results not only in greater vision gain, but also in shorter duration of treatment.
format Online
Article
Text
id pubmed-8805323
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88053232022-02-03 Efficacy of vision therapy for unilateral refractive amblyopia in children aged 7–10 years Hsieh, Yi-Ching Liao, Wen-Ling Tsai, Yi-Yu Lin, Hui-Ju BMC Ophthalmol Research BACKGROUND: There is a critical period for visual development, conventionally considered to be the first 6 years of life. Children aged 7 years and older are significantly less responsive to amblyopia treatment. This study investigated the efficacy of binocular vision therapy in amblyopic children aged 7–10 years. METHODS: This retrospective study enrolled 36 children with unilateral amblyopia who were divided into a case group (receiving vision therapy, optical correction, and part-time patching of the weaker eye) and a control group (receiving optical correction and part-time patching of the weaker eye). Visual acuity (VA) was measured at baseline, at the 3-month, 6-month, and 9-month visits, and 3 months after cessation of treatment. RESULTS: There were 19 subjects in the case group and 17 subjects in the control group. Mean VA in the case group improved from 0.39 ± 0.24 logMAR at baseline to 0.10 ± 0.23 logMAR at the endpoint of treatment (p < 0.001, paired t-test). Mean VA in the control group improved from 0.64 ± 0.30 logMAR at baseline to 0.52 ± 0.27 logMAR at the endpoint of treatment (p = 0.015, paired t-test). The improvement was significantly greater in the case group than in the control group (p = 0.006, two-samples independent t-test). All subjects underwent follow-up examinations within 6 to 12 months. There was no regression of VA in the case group 3 months after cessation of vision therapy. The patients in the case group who received visual therapy were with better VA improvement then patients with only optic correction and patching. CONCLUSIONS: Vision therapy combined with conventional treatment (optical correction and part-time patching) is more effective than conventional treatment alone in children aged 7–10 years with unilateral refractive amblyopia. The treatment results not only in greater vision gain, but also in shorter duration of treatment. BioMed Central 2022-01-31 /pmc/articles/PMC8805323/ /pubmed/35100972 http://dx.doi.org/10.1186/s12886-022-02246-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hsieh, Yi-Ching
Liao, Wen-Ling
Tsai, Yi-Yu
Lin, Hui-Ju
Efficacy of vision therapy for unilateral refractive amblyopia in children aged 7–10 years
title Efficacy of vision therapy for unilateral refractive amblyopia in children aged 7–10 years
title_full Efficacy of vision therapy for unilateral refractive amblyopia in children aged 7–10 years
title_fullStr Efficacy of vision therapy for unilateral refractive amblyopia in children aged 7–10 years
title_full_unstemmed Efficacy of vision therapy for unilateral refractive amblyopia in children aged 7–10 years
title_short Efficacy of vision therapy for unilateral refractive amblyopia in children aged 7–10 years
title_sort efficacy of vision therapy for unilateral refractive amblyopia in children aged 7–10 years
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805323/
https://www.ncbi.nlm.nih.gov/pubmed/35100972
http://dx.doi.org/10.1186/s12886-022-02246-9
work_keys_str_mv AT hsiehyiching efficacyofvisiontherapyforunilateralrefractiveamblyopiainchildrenaged710years
AT liaowenling efficacyofvisiontherapyforunilateralrefractiveamblyopiainchildrenaged710years
AT tsaiyiyu efficacyofvisiontherapyforunilateralrefractiveamblyopiainchildrenaged710years
AT linhuiju efficacyofvisiontherapyforunilateralrefractiveamblyopiainchildrenaged710years